July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
September 2025
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
June 2025
The global pharmaceutical CDMO market size is estimated at USD 184.90 billion in 2024 and is anticipated to reach around USD 368.70 billion by 2034, expanding at a CAGR of 7.2% between 2024 and 2034.
January 2025
The global veterinary CRO and CDMO market size was valued at USD 7.13 billion in 2024 and is predicted to surpass around USD 15.98 billion by 2034 with a CAGR of 8.40%.
June 2025
The global topical drugs CDMO market size was estimated at USD 46.62 billion in 2024 and is predicted to increase from USD 51.79 billion in 2025 to approximately USD 136.39 billion by 2034, expanding at a CAGR of 11.33% from 2025 to 2034.
February 2025
The Europe Pharmaceutical CDMO market size is projected to hit around USD 88.84 billion by 2034 increasing from USD 42.58 billion in 2024, with a CAGR of 7.62%.
July 2025
The global biologics CDMO market size was estimated at USD 21.96 billion in 2024 and is anticipated to reach around USD 92.37 billion by 2034, growing at a solid CAGR of 15.45% from 2025 to 2034.
July 2025
The global personal care CMO and CDMO market size reached USD 28.02 billion in 2024 and is projected to surpass around USD 44.86 billion by 2034 with a CAGR of 4.82%.
September 2025
The global vaccine CDMO market size was evaluated at USD 4.67 billion in 2024 and is predicted to hit around USD 11.16 billion by 2034, growing at a CAGR of 9.10%.
May 2025
The global small molecule innovator CDMO market size was valued at USD 53.07 billion in 2024 and is estimated to hit around USD 97.67 billion by 2034 with a CAGR of 6.29%.
June 2025
The global investigational new drug CDMO market size is estimated to hit around USD 10.26 billion by 2034 from USD 5.25 billion in 2024, with a CAGR of 6.93%.
August 2025
The global sterile injectables CDMO market size is estimated to hit around USD 10.91 billion by 2034 from USD 4.31 billion in 2024, with a CAGR of 9.73%.
June 2025
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,496.69 million by 2034 from USD 55.19 million in 2024, at a CAGR of 39.10%.
June 2025
The global mRNA therapeutics CDMO market size is estimated to hit around USD 13.36 billion by 2034 from USD 4.57 billion in 2024, with a CAGR of 11.32%.
August 2025
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
September 2025
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
September 2025
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
September 2025
The global LNP CDMO market size was evaluated at USD 205.47 million in 2024 and is predicted to hit around USD 820.46 million by 2034, growing at a CAGR of 14.85%.
September 2025
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2025
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
March 2025
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 96.57 billion by 2034, increasing from USD 45.43 billion in 2024, with a CAGR of 7.90%.
September 2025
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com